Tesaro

Global biopharma innovating medicines in respiratory, immunology, oncology, HIV, and infectious diseases

placeWaltham, Massachusetts, United States calendar_todayFounded 2010 groups502 employees language tesarobio.com

Innovation

40 patent families (17 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 6,302 times.

YearFilings
20151
20161
20173
201819
201917
202020
202118
202212
202318
202416
202516
20264

Investor mix

16 investors on record; lead investors include New Enterprise Associates, Kleiner Perkins; 5 have since exited.

Investor typeCountShare
Venture capital744%
Private equity531%
Bank & private debt16%
Other / undisclosed319%
Coming soon